Jennifer A. Sealey-Voyksner
Hoofd Techniek/Wetenschap/O&O bij ENTERO THERAPEUTICS, INC.
Profiel
Jennifer A.
Sealey-Voyksner is the founder of ImmunogenX, Inc., a company founded in 2013.
She held the title of Director & Chief Scientific Officer from 2013 to 2024.
Currently, Dr. Sealey-Voyksner is the Vice President-Research & Development at First Wave Biopharma, Inc., starting in 2024.
Actieve functies van Jennifer A. Sealey-Voyksner
| Bedrijven | Functie | Begin |
|---|---|---|
| ENTERO THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 13-03-2024 |
Eerdere bekende functies van Jennifer A. Sealey-Voyksner
| Bedrijven | Functie | Einde |
|---|---|---|
ImmunogenX LLC
 ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Oprichter | 13-03-2024 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENTERO THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
ImmunogenX LLC
ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Health Technology |
